Skip to main content
Premium Trial:

Request an Annual Quote

Two UK Institutes to Use InforSense Platform for Mental Health Biomarker Studies

NEW YORK (GenomeWeb News) – InforSense said today that it has struck agreements with two UK research institutes who will use its translational research tools to develop diagnostic tools for mental health and in Alzheimer’s disease studies.
InforSense said that the National Institute of Health Research’s Biomedical Research Center for Mental Health, and the Maudsley National Health Service Foundation Trust and Institute of Psychiatry, Kings College London, will use its InforSense solution to help access, handle, and visualize data from biomarker research. 
The company’s translational research solution includes the InforSense platform, Clinical Sense, GenSense, BioSense, and the VisualSense Portal.
Scientists at the Biomedical Research Center for Mental Health will use the platform to integrate and analyze patient, genotyping, transcriptomics, proteomics, and MRI data in pursuit of biomarkers.
The company said that the InforSense platform will enable researchers and clinicians to access their entire patient and ‘omics data through a common interface, and that it will help them eliminate errors associated with manual data handling and bottlenecks to data access.
Financial terms of the agreements were not released.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.